Benefits of deacetylase inhibitors for leukemia therapy
Inotuzumab and blinatumomab: the most exciting ALL news from EHA 2017
Side effects of novel drugs and managing patient expectations in CLL
Why should elderly AML patients take part in clinical trials?
Targeting apoptosis - developing drugs to inhibit Bcl-2 and Mcl-1